MedPath

圣大(张家口)药业有限公司

Ownership
-
Established
2002-08-15
Employees
-
Market Cap
-
Website
http://www.shengdayaoye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

119

NMPA:119

Drug Approvals

Penicillin V Potassium Buccal Tablets

Product Name
青霉素Ⅴ钾口含片
Approval Number
国药准字H20080104
Approval Date
May 4, 2023
NMPA

Aminopyrine,Caffeine and Calcium Glycerophosphate Tablets

Product Name
氨咖甘片
Approval Number
国药准字H20045383
Approval Date
Sep 28, 2020
NMPA

小儿牛黄散

Approval Number
国药准字Z13021625
Approval Date
Sep 28, 2020
NMPA

Oxytetracycline Tablets

Product Name
土霉素片
Approval Number
国药准字H13020472
Approval Date
Sep 28, 2020
NMPA

Cefadroxil Capsules

Product Name
头孢羟氨苄胶囊
Approval Number
国药准字H13020462
Approval Date
Sep 28, 2020
NMPA

Rifandine capsules

Product Name
利福定胶囊
Approval Number
国药准字H13023785
Approval Date
Sep 28, 2020
NMPA

Pentoxyverine Citrate Tablets

Product Name
枸橼酸喷托维林片
Approval Number
国药准字H20045382
Approval Date
Sep 28, 2020
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H13020465
Approval Date
Sep 28, 2020
NMPA

Rifampicin Tablets

Product Name
利福平片
Approval Number
国药准字H13020467
Approval Date
Sep 28, 2020
NMPA

Cefalexin Granules

Product Name
头孢氨苄颗粒
Approval Number
国药准字H13020464
Approval Date
Sep 28, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.